| pubmed-article:12643457 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12643457 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12643457 | lifeskim:mentions | umls-concept:C0007202 | lld:lifeskim |
| pubmed-article:12643457 | lifeskim:mentions | umls-concept:C1705480 | lld:lifeskim |
| pubmed-article:12643457 | lifeskim:mentions | umls-concept:C1963944 | lld:lifeskim |
| pubmed-article:12643457 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12643457 | pubmed:dateCreated | 2003-3-19 | lld:pubmed |
| pubmed-article:12643457 | pubmed:abstractText | Hypotension refractory to maximal doses of alpha-adrenergic drugs after cardiac operations employing cardiopulmonary bypass (CPB) has been referred as "vasoplegic syndrome." Vasopressin has been used for its therapy with encouraging results. | lld:pubmed |
| pubmed-article:12643457 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12643457 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12643457 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12643457 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12643457 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12643457 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12643457 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12643457 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12643457 | pubmed:issn | 0886-0440 | lld:pubmed |
| pubmed-article:12643457 | pubmed:author | pubmed-author:MasettiPaoloP | lld:pubmed |
| pubmed-article:12643457 | pubmed:author | pubmed-author:MurphySuzan... | lld:pubmed |
| pubmed-article:12643457 | pubmed:author | pubmed-author:KouchoukosNic... | lld:pubmed |
| pubmed-article:12643457 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12643457 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:12643457 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12643457 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12643457 | pubmed:pagination | 485-9 | lld:pubmed |
| pubmed-article:12643457 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:meshHeading | pubmed-meshheading:12643457... | lld:pubmed |
| pubmed-article:12643457 | pubmed:articleTitle | Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass. | lld:pubmed |
| pubmed-article:12643457 | pubmed:affiliation | Division of Cardiovascular and Thoracic Surgery and the Heart Center, Missouri Baptist Medical Center, St. Louis, Missouri, USA. | lld:pubmed |
| pubmed-article:12643457 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12643457 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12643457 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12643457 | lld:pubmed |
